HOB BIOTECH(SH:688656) Cai Jing Wang·2025-10-30 10:04Core Insights - The company reported a decline in revenue and net profit for the first three quarters of 2025, with total revenue at 292 million yuan, down 4.8% year-on-year, and net profit attributable to shareholders at 26.19 million yuan, down 1.4% [1] - The third quarter showed a slight decrease in revenue but a significant increase in net profit, with revenue at 103 million yuan, down 1.6% year-on-year, while net profit rose 113% to 14.02 million yuan [1] - The company's total assets decreased by 6.5% year-on-year to 965 million yuan, while net assets attributable to shareholders increased by 2.1% to 829 million yuan [1] Financial Performance - Total revenue for the first three quarters was 292 million yuan, a decrease of 4.8% year-on-year [1] - Net profit attributable to shareholders for the same period was 26.19 million yuan, down 1.4% [1] - The net profit for the third quarter was 14.02 million yuan, an increase of 113% year-on-year [1] - The company reported a net cash flow from operating activities of 57.67 million yuan, down 24.5% year-on-year [1] Earnings Per Share - The fully diluted EPS for the first three quarters was 0.4126 yuan [1] - The EPS for the third quarter was 0.2209 yuan [1] Research and Development - The company's total R&D expenditure was 11.89 million yuan, accounting for 11.6% of total revenue [1]